(Q44777694)

6 December 2017

title

Oxidative stress in white coat hypertension; role of paraoxonase (English)

1 reference

6 December 2017

Uzun H

1

1 reference

6 December 2017

Karter Y

2

1 reference

6 December 2017

Aydin S

3

1 reference

6 December 2017

Curgunlu A

4

1 reference

6 December 2017

Simşek G

5

1 reference

6 December 2017

Yücel R

6

1 reference

6 December 2017

Vehiyd S

7

1 reference

6 December 2017

Ertürk N

8

1 reference

6 December 2017

Kutlu A

9

1 reference

6 December 2017

Benian A

10

1 reference

6 December 2017

Yaldiran A

11

1 reference

6 December 2017

Oztürk E

12

1 reference

6 December 2017

Erdine S

13

1 reference

6 December 2017

publication date

1 July 2004

1 reference

Journal of Human Hypertension

6 December 2017

published in

1 reference

6 December 2017

volume

18

1 reference

6 December 2017

issue

7

1 reference

6 December 2017

page(s)

523-528

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.jhh.1001697

6 December 2017

exact match

0 references

cites work

Malondialdehyde, lipofuscin and activity of antioxidant enzymes during physical exercise in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001697

Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001697

The oxidation hypothesis of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001697

3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Inhibitors Protect Against Oxidized Low-Density Lipoprotein-Induced Endothelial Dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001697

Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001697

Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001697

Catalase and paraoxonase in hypertensive type 2 diabetes mellitus: correlation with glycemic control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001697

Paraoxonase as a risk marker for cardiovascular disease: facts and hypotheses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001697

Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001697

Psychophysiological reactivity and cardiac end-organ changes in white coat hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001697

Different metabolic predictors of white-coat and sustained hypertension over a 20-year follow-up period: a population-based study of elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001697

"White coat" versus "sustained" borderline hypertension in Tecumseh, Michigan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001697

Guidelines for management of hypertension: report of the third working party of the British Hypertension Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001697

Blood pressure measuring devices: recommendations of the European Society of Hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001697

Use and interpretation of ambulatory blood pressure monitoring: recommendations of the British hypertension society

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001697

Elevation of oxidative stress in the aorta of genetically hypertensive mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001697

Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001697

NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001697

Antioxidant Activities and Oxidative Stress Byproducts in Human Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001697

Low-density lipoprotein oxidation and vitamins E and C in sustained and white-coat hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001697

Relationship between lipoprotein(a) levels, oxidative stress, and blood pressure levels in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001697

Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001697

7 January 2021

Recommendations for routine blood pressure measurement by indirect cuff sphygmomanometry. American Society of Hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001697

7 January 2021

Microsomal lipid peroxidation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001697

7 January 2021

Paraoxonase polymorphisms are not associated with cardiovascular risk in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001697

7 January 2021

Influence of serum paraoxonase polymorphism on serum lipids and apolipoproteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001697

7 January 2021

Effect of gamma-tocotrienol on blood pressure, lipid peroxidation and total antioxidant status in spontaneously hypertensive rats (SHR)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001697

7 January 2021

The role of hydrogen peroxide in the contractile response to angiotensin II

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001697

7 January 2021

Noninvasive study of endothelial function in white coat hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001697

7 January 2021

Endothelial dysfunction in sustained and white coat hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001697

7 January 2021

Identifiers

DOI

10.1038/SJ.JHH.1001697

1 reference

6 December 2017

1 reference